Aesthetic Dermatology

Topical Botulinum Toxin Will Turn Market 'Upside Down'

Publish date: April 26, 2012

 

EXPERT ANALYSIS FROM THE SDEF HAWAII DERMATOLOGY SEMINAR

SDEF and this news organization are owned by Elsevier.

Naseem Miller was a contributing writer.

Pages

Recommended Reading

Economic Forecast: Rough Road Ahead for Dermatologists
MDedge Dermatology
Skin of Color: The Lack of Insurance Coverage for Melasma
MDedge Dermatology
Cosmeceutical Critique: Ginkgo Biloba
MDedge Dermatology
Topical Hyaluronic Acid Is Breaking Through Dermis
MDedge Dermatology
Skin of Color: Cosmeceutical Lightening Agents
MDedge Dermatology
Foot-Pedal Device May Ease Filler Injections
MDedge Dermatology
Promising New Cellulite Therapies Target Fibrous Septae
MDedge Dermatology
Skin of Color: Ethnic Differences in Skin Architecture
MDedge Dermatology
Indocyanine Green-Augmented Laser Therapy Is Shrinking Vessels
MDedge Dermatology
Botanicals on Par With Hydroquinone for Treating Melasma
MDedge Dermatology